XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 01, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Mar. 31, 2020
Dec. 31, 2019
Dec. 18, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of common shares available for future issuance 2,186,215 11,073,439   11,073,439   34,917,408    
Common shares reserved for grant (in shares)   5,101,557   5,101,557   5,283,520    
Weighted average fair value at the grant date (in dollars per share)   $ 23.26 $ 5.63 $ 16.05 $ 5.26      
Unrecognized equity-based compensation related to unvested stock options   $ 47,100   $ 47,100        
Remaining weighted average service period for recognition   2 years 10 months 24 days            
Share based compensation expense   $ 3,307 $ 3,119 7,225 $ 3,656      
Research and Development Expense                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share based compensation expense   951 2,306 1,370 2,369      
General and Administrative Expense                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share based compensation expense   2,356 813 $ 5,855 $ 1,287      
Restricted stock units (unvested)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Restricted stock units, grants in period (in shares)       127,200        
Unrecognized equity-based compensation related to unvested stock options   $ 2,000   $ 2,000        
Remaining weighted average service period for recognition   1 year 7 months 6 days            
Roivant Sciences Ltd. (RSL) | Research and Development Expense                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share based compensation expense   $ 100 $ 100          
2019 Equity Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of common shares available for future issuance   5,101,557   5,101,557     5,500,000  
Maximum number of shares issued             16,500,000  
Percentage of common stock outstanding 4.00%              
Common shares reserved for grant (in shares)   2,457,458   2,457,458        
2019 Equity Incentive Plan | Restricted stock units (unvested)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Restricted stock units, grants in period (in shares)       127,200        
2018 Equity Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common shares reserved for grant (in shares)   3,377,224   3,377,224        
Number of shares assumed and converted into options to purchase shares (in shares)               4,408,287